Chimerix, Inc.
CMRX
$8.54
-$0.01-0.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 57.00K | 26.00K | 129.00K | -- | 4.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 57.00K | 26.00K | 129.00K | -- | 4.00K |
| Cost of Revenue | 22.29M | 18.30M | 18.43M | 20.34M | 21.26M |
| Gross Profit | -22.24M | -18.27M | -18.30M | -20.34M | -21.26M |
| SG&A Expenses | 6.95M | 5.17M | 4.53M | 6.05M | 5.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.61M | 24.82M | 22.96M | 26.39M | 20.81M |
| Operating Income | -24.55M | -24.79M | -22.83M | -26.39M | -20.81M |
| Income Before Tax | -22.95M | -22.88M | -20.69M | -21.87M | -18.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.95M | -22.88M | -20.69M | -21.87M | -18.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.95M | -22.88M | -20.69M | -21.87M | -18.16M |
| EBIT | -24.55M | -24.79M | -22.83M | -26.39M | -20.81M |
| EBITDA | -24.53M | -24.77M | -22.81M | -26.37M | -20.79M |
| EPS Basic | -0.25 | -0.26 | -0.23 | -0.25 | -0.20 |
| Normalized Basic EPS | -0.16 | -0.16 | -0.14 | -0.17 | -0.13 |
| EPS Diluted | -0.26 | -0.26 | -0.23 | -0.25 | -0.21 |
| Normalized Diluted EPS | -0.16 | -0.16 | -0.14 | -0.17 | -0.13 |
| Average Basic Shares Outstanding | 90.26M | 89.70M | 89.63M | 89.26M | 88.91M |
| Average Diluted Shares Outstanding | 90.26M | 89.70M | 89.63M | 89.26M | 88.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |